Tethys BioScience

Biological Markers for Diagnoses

Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test...

Founded in 2002
Total money raised: $30.4M

94608 5858 Horton Street
Suite 550


Phone: 510-420-6700

Updated on May 6, 2013
Tethys BioScience at CrunchBase
Mickey S. Urdea Co - Founder
David Chernoff Chief Medical Officer
Randy Strahan President & Chief Executive Officer & Board Member
Dr .Urdea Founder & CEO
John Hollister Senior Vice President, Marketing
Juan P. Frias Chief Medical Officer
Mani Grewal Director, Informatics Operations
Brook Byers Board Member
Bill Ericson Board Member
George Rehm Board Member
Caitlyn Waller Krebs Director, Business Development
Frances Chin Lee Director, Clinical Lab Operations
Steve Eichenlaub Board Member
Lawrence Leisure Board Member
Gregory T. Went Board Member
David Hodgson Founder & Chief Technology Officer
Mohan Iyer Chief Financial and Business Officer
R. Michael Richey Chief Business Officer / President
Matt Ferguson CFO

November, 2009

Tethys BioScience raised $25M in a Series D round from Aeris Capital, Wasatch Advisors, Intel Capital, Kleiner Perkins Caufield & Byers, and Mohr Davidow Ventures

Tethys picks up $25M for diabetes diagnostic

September, 2008

Tethys BioScience acquired Lipomics Technologies

Tethys Bioscience Announces Acquisition of Lipomics Technologies

October, 2005

Tethys BioScience raised $5.4M in a Series A round from Mohr Davidow Ventures


Tethys BioScience was founded in 2002